CoChat

Computational pathology in 2030: a Delphi study forecasting the role of AI in pathology within the next decade

Open access
Berbís, M. Alvaro, McClintock, David S., Bychkov, Andrey, Van der Laak, Jeroen, Pantanowitz, Liron, Lennerz, Jochen K., Cheng, Jerome Y., Delahunt, Brett, Egevad, Lars, Eloy, Catarina, Farris, Alton B., Fraggetta, Filippo, García del Moral, Raimundo, Hartman, Douglas J., Herrmann, Markus D., Hollemans, Eva, Iczkowski, Kenneth A., Karsan, Aly, Kriegsmann, Mark, Salama, Mohamed E., Sinard, John H., Tuthill, J. Mark, Williams, Bethany, Casado-Sánchez, César, Sánchez-Turrión, Víctor, Luna, Antonio, Aneiros-Fernández, José, Shen, Jeanne · 2023 · eBioMedicine
Cited by 113

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Artificial intelligence (AI) is rapidly fuelling a fundamental transformation in the practice of pathology. However, clinical integration remains challenging, with no AI algorithms to date in routine adoption within typical anatomic pathology (AP) laboratories. This survey gathered current expert perspectives and expectations regarding the role of AI in AP from those with first-hand computational pathology and AI experience. METHODS: Perspectives were solicited using the Delphi method from 24 subject matter experts between December 2020 and February 2021 regarding the anticipated role of AI in pathology by the year 2030. The study consisted of three consecutive rounds: 1) an open-ended, free response questionnaire generating a list of survey items; 2) a Likert-scale survey scored by experts and analysed for consensus; and 3) a repeat survey of items not reaching consensus to obtain further expert consensus. FINDINGS: Consensus opinions were reached on 141 of 180 survey items (78.3%). Experts agreed that AI would be routinely and impactfully used within AP laboratory and pathologist clinical workflows by 2030. High consensus was reached on 100 items across nine categories encompassing the impact of AI on (1) pathology key performance indicators (KPIs) and (2) the pathology workforce and specific tasks performed by (3) pathologists and (4) AP lab technicians, as well as (5) specific AI applications and their likelihood of routine use by 2030, (6) AI's role in integrated diagnostics, (7) pathology tasks likely to be fully automated using AI, and (8) regulatory/legal and (9) ethical aspects of AI integration in pathology. INTERPRETATION: This systematic consensus study details the expected short-to-mid-term impact of AI on pathology practice. These findings provide timely and relevant information regarding future care delivery in pathology and raise key practical, ethical, and legal challenges that must be addressed prior to AI's successful clinical implementation. FUNDING: No specific funding was provided for this study.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ebiom.2022.104427

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 113

Metadata

Authors
Berbís, M. A., McClintock, D. S., Bychkov, A., Van der Laak, J., Pantanowitz, L., Lennerz, J. K., Cheng, J. Y., Delahunt, B., Egevad, L., Eloy, C., Farris, A. B., Fraggetta, F., García del Moral, R., Hartman, D. J., Herrmann, M. D., Hollemans, E., Iczkowski, K. A., Karsan, A., Kriegsmann, M., Salama, M. E., Sinard, J. H., Tuthill, J. M., Williams, B., Casado-Sánchez, C., Sánchez-Turrión, V., Luna, A., Aneiros-Fernández, J., & Shen, J.
Venue
eBioMedicine
Publisher
Elsevier BV
Published
2023-02
Volume
88
Pages
104427
ISSN
2352-3964 (ISSN-L)
OpenAlex
W4313594376
Cited by
113
References
18
FWCI
3.88
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.